Synthesis and results of biological evaluation of two types of water-solubl
e polymer drug carrier systems designed for site-specific therapy are descr
ibed. In the first system, a nondegradable poly[N-(2-hydroxypropyl)methacry
lamide] (PHPMA) bears biodegradable oligopeptide side chains, terminated in
the targeting antibody and/or anti-cancer drug doxorubicin, randomly distr
ibuted along the polymer chain. The other system is based on PEG (M-w 2000)
blocks connected with biodegradable N-2,N-6-bis(glutamyl)-lysine oligopept
ide links. This linear water-soluble polymer bears doxorubicin attached to
the carboxylic groups of amino acid residues in the oligopeptide links via
biodegradable GlyPheLeuGly spacer.
Both systems release doxorubicin in vitro after incubation with lysosomal e
nzyme cathepsin B and exhibit in vivo anti-cancer activity in the treatment
of selected model mice cancers. PHPMA, PEG and PHPMA-drug carriers, if con
jugated with the antibody to form antibody-targeted systems, significantly
decrease its immunogenicity (approx. by order of magnitude two).